middle.news
How Hydration Pharmaceuticals Halved Its Losses While Cutting Revenue 15%
4:15am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Hydration Pharmaceuticals Halved Its Losses While Cutting Revenue 15%
4:15am on Saturday 30th of August, 2025 AEST
Key Points
Half-year loss narrowed 55% to $1.44 million
Revenue declined 15% to $1.53 million due to SKU rationalisation
Gross margin maintained at 97% despite lower sales
Cost-cutting and US-only focus improved operational efficiency
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
The Hydration Pharmaceuticals Company (ASX:HPC)
OPEN ARTICLE